Virtu Financial’s bioAffinity Technologies BIAF Stock Holding History

Virtu Financial’s Portfolio BIAF Stock Details BIAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9K	Buy	+741	New	+$22.7K	﹤0.01%	1449

Other funds holding BIAF

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial's BIAF Position: Q2 2026 in Review

Virtu Financial opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 741 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #1449 among its holdings.

19 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

Virtu Financial held 741 shares of bioAffinity Technologies worth $9K as of Q2 2026.
bioAffinity Technologies was a new Virtu Financial position in Q2 2026.
bioAffinity Technologies made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1449 holding.
19 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.